SERPINA3 and inflammatory bowel disease: There were significantly higher Act A levels in overweight IBD patients compared to those with normal BMI (34.3 pg/mL vs. 31.2 pg/mL; p = 0.0192), as well as compared to underweight patients (31.9 pg/mL; p = 0.0421).